NasdaqGM - Nasdaq Real Time Price USD
KalVista Pharmaceuticals, Inc. (KALV)
13.55
-0.05
(-0.37%)
At close: May 2 at 4:00:00 PM EDT
14.30
+0.75
+(5.54%)
Pre-Market: 8:27:12 AM EDT
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-127,648
-89,231
-75,261
-78,134
-30,171
Investing Cash Flow
-31,834
-84,719
41,415
57,860
-147,654
Financing Cash Flow
305,166
150,714
58,116
1,581
212,117
End Cash Position
168,740
31,789
56,238
30,732
50,592
Capital Expenditure
-536
-443
-1,196
-931
-82
Issuance of Capital Stock
152,856
96,945
56,582
--
210,582
Free Cash Flow
-128,184
-89,674
-76,457
-79,065
-30,253
4/30/2021 - 4/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PHVS Pharvaris N.V.
18.37
+2.91%
URGN UroGen Pharma Ltd.
11.51
+0.88%
EWTX Edgewise Therapeutics, Inc.
16.91
+1.38%
VRDN Viridian Therapeutics, Inc.
13.62
-0.87%
REPL Replimune Group, Inc.
10.01
+3.84%
NUVB Nuvation Bio Inc.
2.4600
+8.37%
TARS Tarsus Pharmaceuticals, Inc.
47.36
-5.84%
RGNX REGENXBIO Inc.
10.40
+5.80%
IKNA Ikena Oncology, Inc.
1.2500
+2.46%
TVTX Travere Therapeutics, Inc.
21.15
+1.88%